Principia Biopharma - Ownership and Business Overview

Life ScienceCompany

Principia Biopharma Ownership

Who owns Principia Biopharma?

Principia Biopharma is owned by Sanofi SA. It was acquired on August 17, 2020.

Was Principia Biopharma formerly PE-backed?

Yes. Principia Biopharma was formerly owned by 1 private investor.

Principia Biopharma Business Overview

Where is Principia Biopharma headquartered?

Principia Biopharma is headquartered in South San Francisco, California.

What sector is Principia Biopharma in?

Principia Biopharma is a life science company.

When was Principia Biopharma founded?

Principia Biopharma was founded in 2008.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 284 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 261 by strategics.

Principia Biopharma, Inc.

220E Grand Avenue,
South San Francisco, California 94080
United States,
(650) 416-7700
www.principiabio.com

Principia Biopharma, Inc. is a private, clinical-stage bio pharmaceutical company, has created a revolutionary new way to design and develop oral small molecule therapies that are more potent, selective, durable and safer than currently available drugs. Principia Biopharma was founded in 2008 and is based in South San Francisco, California.


 Subscribe to unlock this and 206,067
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.